Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Omalizumab induced remission of idiopathic anaphylaxis in a patient suffering from indolent systemic mastocytosis.

× No keyword cloud information.

16 in total

Review 1. Off-Label Uses of Omalizumab.

Authors: David El-Qutob
Journal: Clin Rev Allergy Immunol Date: 2016-02 Impact factor: 8.667

2. Mast cell disorders: Protean manifestations and treatment responses.

Authors: Meng Chen; Alexander Kim; Bruce Zuraw; Taylor A Doherty; Sandra Christiansen
Journal: Ann Allergy Asthma Immunol Date: 2018-03-28 Impact factor: 6.347

Review 3. Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy.

Authors: Christian Vestergaard; Mette Deleuran
Journal: Ther Adv Chronic Dis Date: 2015-11 Impact factor: 5.091

Review 4. Advances in anti-IgE therapy.

Authors: Arzu Didem Yalcin
Journal: Biomed Res Int Date: 2015-05-05 Impact factor: 3.411

Review 5. An overview of the effects of anti-IgE therapies.

Authors: Arzu Didem Yalcin
Journal: Med Sci Monit Date: 2014-09-22

6. Cutaneous and gastrointestinal symptoms in two patients with systemic mastocytosis successfully treated with omalizumab.

Authors: Sofie Lieberoth; Simon Francis Thomsen
Journal: Case Rep Med Date: 2015-01-28

Review 7. Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes.

Authors: David González-de-Olano; Almudena Matito; Alberto Orfao; Luis Escribano
Journal: F1000Res Date: 2016-11-14

Review 8. IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.

Authors: Arnau Navinés-Ferrer; Eva Serrano-Candelas; Gustavo-J Molina-Molina; Margarita Martín
Journal: J Immunol Res Date: 2016-12-21 Impact factor: 4.818

Review 9. Targeted Treatment Options in Mastocytosis.

Authors: Mélanie Vaes; Fleur Samantha Benghiat; Olivier Hermine
Journal: Front Med (Lausanne) Date: 2017-07-20

Review 10. Pharmacological treatment options for mast cell activation disease.

Authors: Gerhard J Molderings; Britta Haenisch; Stefan Brettner; Jürgen Homann; Markus Menzen; Franz Ludwig Dumoulin; Jens Panse; Joseph Butterfield; Lawrence B Afrin
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2016-04-30 Impact factor: 3.000